期刊论文详细信息
| Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | |
| Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic | |
| Antoni Bayes‐Genis1 Javier Díez2 | |
| [1] Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain;Program of Cardiovascular Diseases, Center for Applied Medical Research, University of Navarra, Pamplona, Spain; | |
| 关键词: Editorials; biomarker; myocardial infarction; non–ST‐segment elevation acute coronary syndrome; risk stratification; ST‐segment elevation myocardial infarction; | |
| DOI : 10.1161/JAHA.117.007665 | |
| 来源: DOAJ | |
【 授权许可】
Unknown
878987797
028-85220240
